XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues:        
Total revenues   $ 466,785   $ 466,785
Operating expenses:        
Research and development $ 7,350,035 4,277,052 $ 12,993,064 8,093,670
General and administrative 3,559,150 2,547,289 6,697,108 5,374,284
Total operating expenses 10,909,185 6,824,341 19,690,172 13,467,954
Loss from operations (10,909,185) (6,357,556) (19,690,172) (13,001,169)
Other income:        
Change in fair value of warrant liabilities 0 0 0 31,000
Interest income 2,403 15,857 3,940 142,826
Net loss $ (10,906,782) $ (6,341,699) $ (19,686,232) $ (12,827,343)
Net loss per share, basic and diluted $ (0.13) $ (0.14) $ (0.28) $ (0.28)
Weighted average number of common shares outstanding, basic and diluted 83,030,470 46,572,739 69,823,729 46,328,561
Grant income        
Revenues:        
Total revenues   $ 466,785   $ 466,785